Nail penetration of the antifungal agent oxiconazole after repeated topical application in healthy volunteers, and the effect of acetylcysteine

European Journal of Pharmaceutical Sciences

Volumn 5, Issue 3, 1997, Pages 119-127

  Van Hoogdalem, E J ^a   Van Den Hoven, W E ^a   Terpstra, I J ^a   Van Zijtveld, J ^a   Verschoor, J S C ^a   Visser, J N ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Acetylcysteine; Nail penetration; Oxiconazole; Volunteers

Indexed keywords

ACETYLCYSTEINE; ANTIFUNGAL AGENT; OXICONAZOLE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG PENETRATION; DRUG TOLERABILITY; DRUG UPTAKE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NAIL; NORMAL HUMAN; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION; VOLUNTEER;

EID: 0030973380     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(97)00270-4     Document Type: Article

References (13)

1. Chiou, W.L. (1978) Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. J. Pharmacokin. Biopharm., 6, 539-546.
2. Finlay, A.Y. (1992) Pharmacokinetics of terbinafine in the nail. J. Dermatol. Treat. 3, Suppl 1, 15-17.
3. Jegasothy, B.V. and Pakes, G.E. (1991) Oxiconazole nitrate: pharmacology, efficacy and safety of a new imidazole antifungal agent. Clin. Ther. 13, 126-141.
4. Matthieu, L., De Doncker, P., Cauwenbergh, G., Woestenborghs, R., Van De Velde, V., Janssen, P.A.J. and Dockx, P. (1991) Itraconazole penetrates the nail via the nail matrix and the nail bed - an investigation in onychomycosis. Clin. Exp. Dermatol. 16, 374-376.
5. Polak, A. (1993) Kinetics of amorolfine in human nails. Mycoses 36, 101-103.
6. Reinel, D. and Clarke, C. (1992) Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once-weekly versus twice-weekly. Clin. Exp. Dermatol. Suppl. 17, 44-49.
7. Roseeuw, D. and De Doncker, P. (1993a) New therapeutic concepts for the treatment of onychomycosis. J. Eur. Acad. Dermatol. Venereol. 2, Suppl 1, S34-S38.
8. Roseeuw, D. and De Doncker, P. (1993b) New approaches to the treatment of onychomycosis. J. Am. Acad. Dermatol. 29, S45-S49.
9. Rowland, M. and Tozer, T. (1989) Clinical pharmacokinetics: concepts and applications, 2nd edn. Lea and Febiger, Philadelphia, pp. 479-483.
10. Schäfer-Korting, M. (1993) Pharmacokinetic optimisation of oral antifungal therapy. Clin. Pharmacokin. 25, 329-341.
11. Stüttgen, G. and Bauer, E. (1982) Bioavailability, skin- and nail penetration of topically applied antimycotics. Mykosen. 25, 74-80.
12. Stüttgen, G. (1989) Penetrationsförderung lokal applizierter Wirkstoffe durch Harnstoff. Hautarzt, suppl. 9, 27-31.
13. Zaias, N. (1990) The nail in health and disease, 2nd edn. Appleton and Lange, Norwalk, pp. 87-105.